share_log

普利制药:关于全资子公司安徽普利药业有限公司环磷酰胺原料药收到FDA接收通知函的公告

Pulley Pharmaceutical: Announcement on the receipt of a notification letter from the FDA for cyclophosphamide APIs of Anhui Puli Pharmaceutical Co., Ltd., a wholly-owned subsidiary

Jul 27, 2022 04:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more